ImpediMed Limited (ASX:IPD) Insider Andrew Grant Buys 1,000,000 Shares

ImpediMed Limited (ASX:IPD) insider Andrew Grant purchased 1,000,000 shares of the stock in a transaction dated Friday, August 30th. The shares were acquired at an average cost of A$0.05 ($0.03) per share, for a total transaction of A$50,000.00 ($34,013.61).

ImpediMed Stock Performance

The company has a debt-to-equity ratio of 2.50, a quick ratio of 6.23 and a current ratio of 7.00.

ImpediMed Company Profile

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications.